In this study we tried to answer two questions and established two hypotheses. First, does premedication with flunitrazepam lower the core temperature significantly? Second, does prewarming have an effect on core temperature at the beginning of surgery? In this randomized controlled trial we demonstrated that premedication with flunitrazepam lowered the core temperature significantly. Further, we were able to observe that the core temperature of the patients in the prewarming group was significantly higher at the beginning of surgery compared to those of the control group. Therefore we were able to confirm both hypotheses. However, a short period of prewarming with forced-air was not able to restore the core temperature to the baseline level before premedication.
Premedication of patients with benzodiazepines
Sedative and anxiolytic premedication is widely administered before surgery although little clinical evidence supports its use [17, 18]. In the last year routine premedication of patients with benzodiazepines has been questioned for several reasons. First, in a prospective randomized trial in patients undergoing elective surgery under general anaesthesia, premedication with lorazepam compared with placebo or no premedication failed to improve the self-reported patient experience. Even in a subgroup of the most anxious patients no significant differences were found in the global patient experience, even though anxiety of the treated patients was less compared to placebo. In contrast to these small differences induced by anxiolytic medication with a benzodiazepine there were clear disadvantages of this treatment. The time to extubation was modestly prolonged and patients had a lower rate of early cognitive recovery [17].
Second, the treatment of surgical patients with benzodiazepines is associated with postoperative delirium, especially in elderly patients [18, 19]. Postoperative delirium is a devastating complication that is clearly associated with increased mortality [18, 20, 21].
Influence of premedication with benzodiazepines on perioperative core temperature
Until now, it is not clear if premedication with benzodiazepines increases the risk of perioperative hypothermia. The effects of benzodiazepines on perioperative core temperature have been studied with conflicting results. In a well conducted study in young and healthy volunteers Kurz et al. [11] found that even high doses of midazolam (about 40 mg in 4 h) had only moderate effects on autonomic thermoregulation. In addition, Toyota et al. [22] found no difference in core temperature after patients were premedicated with 0.04 mg.kg− 1 or 0.08 mg.kg− 1 midazolam i.m. 30 min before induction of anaesthesia. Maurice-Szamburski et al. [17] also found no difference in core temperature at induction of anaesthesia when patients received 2.5 mg Lorazepam p.o. or not.
In contrast, Gilbert et al. [23] found that core temperature of volunteers decreased about 0.3 °C after administration of 30 mg of temazepam p.o.. A similar result was obtained by Matsukawa et al. [24] in young healthy volunteers. They found that midazolam given i.m. had a clear dose dependent effect on core temperature 30 min after administration with a drop in core temperature of more than 0.5 °C when 0.075 mg.kg− 1 midazolam were given. In another study administration of 0.075 mg.kg− 1 midazolam i.m. was also associated with a drop of core temperature of 0.5 °C [12]. These results are comparable to the results of our study in which core temperature dropped 0.3 °C between administration of flunitrazepam and induction of anaesthesia. The drop in core temperature seems to be depending on the level of sedation, with the patients being more sedated having the bigger drop in core temperature [22, 24]. This effect could also be seen in our study.
Today we can only speculate about the effect of premedication with benzodiazepines on the incidence of perioperative hypothermia. In one clinical study [17], premedication with a benzodiazepine had no influence on the postoperative core temperature. However, only 50% of the patients were warmed actively and it is difficult to rule out an effect of the premedication on intraoperative and postoperative core temperature. In a second clinical study [22] premedicated patients had a smaller drop in intraoperative core temperature compared to patients without premedication. However, in both studies premedication did not lower core temperature before induction of anaesthesia as we have observed. When patients arrive in the operating room with a significant lower core temperature it seems reasonable to assume that this would lead to a lower intraoperative core temperature and a higher incidence of perioperative hypothermia. This seems especially true, if this drop in core temperature, as we have shown in our study, cannot be offset by active prewarming. This result is in contrast to the findings of Sato et al. [12] who observed that prewarming did not prevent a transient decrease in core temperature by midazolam, but increased the temperature to the control level thereafter. However, in our study active prewarming was started about 40 min after premedication and not at the time of premedication.
Active prewarming before induction of anaesthesia reduced significantly the further drop in core temperature after induction of anaesthesia and thereby the incidence of hypothermia at the beginning of surgery. Therefore we would like to underline the importance of prewarming, especially in premedicated patients.
Strengths and weaknesses of the study
The study was conducted with a well validated method of core temperature measurement [13, 14, 25]. In contrast to many other methods of core temperature measurement, the use of a zero-heat flux thermometer allowed us to standardize the measurement and measure core temperature in awake and anaesthetized patients using the same method and the same place. Therefore we did not observe a difference in core temperature when the temperature measurement method was changed as it has been shown quite often [26, 27].
Another strength of this study is that the patients were not young and healthy as in many other studies [11, 12, 22, 24], therefore these patients are more representative for daily real life practice. We decided to conduct this study on a cohort of cardiac surgery patients, first, because these patients are usually not young and healthy. Second, these patients are premedicated with a potent benzodiazepine and third surgery with hypothermic cardio-pulmonary bypass (CPB) allowed us to create a control group of patients without prewarming (contrary to the recommendation of the national guideline [15]).
However, the study also has some weaknesses. It was a single center study with a small number of patients, but a power analysis was done and yielded satisfying results. The fact that flunitrazepam was used as premedication is not necessarily representative for daily practice. And neither weight adjustment nor BMI correlation were considered, for the dosing of the anxiolytic drug followed the standard drug dosing for cardiac surgical patients of our department. However, at least to a certain degree, these results should be comparable to other benzodiazepines.
Open questions
To our opinion it is not clear to which extend the observed results of flunitrazepam are comparable to the effects of other benzodiazepines as midazolam. Further studies will have to clarify whether other benzodiazepines, when administered p.o. on the ward, decrease core temperature to the same extent as flunitrazepam. It remains also unclear whether the use of premedication would be associated with a higher or even lower incidence of perioperative hypothermia if patients are treated with a modern temperature management concept consisting of active prewarming and active warming during anaesthesia.